Explore how space oncology could transform cancer treatment through microgravity research and innovative drug development ...

Acrivon Therapeutics trades below cash value, with the market deeply discounting its platform and pipeline despite promising ...

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

MAIA Biotechnology has reported positive initial efficacy results from its Phase II THIO-101 trial, Part C, involving its ...

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

FuelCell Energy (NasdaqGM:FCEL) has signed a multi phase agreement with Fit Energy USA LP to supply up to 380 megawatts of fuel cell power for data centers. The deal focuses on clean, baseload power ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

As the demand for electric vehicles, renewable energy storage, and portable electronics continues to ...

Subcutaneous amivantamab induced rapid and durable responses among patients with HPV-unrelated recurrent or metastatic head ...

However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...

A phase 3 randomized study found no OS benefit from adding 30 Gy/10 fractions thoracic radiotherapy starting after cycle 1 to ...